Novartis received Health Canada approval for its therapy, Vanrafia, on August 14, 2026.

The entities involved

• Health Canada →

  Department of the Canadian Government that oversees public health

  • Canadian Blood Services faces union calls for contract termination after Health Canada issued a non-compliance rating.Fri 17:53
  • Health Canada approved the new indication for IMCIVREE, a product focused on the North American market, while Jennifer Lee serves as EVP for Rhythm.Fri 15:22
• Novartis →

  Swiss-American multinational pharmaceutical corporation

  • Novartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Sat 01:46
  • GSK and Novartis are identified as major pharmaceutical companies.Fri 02:16

Related events

• Novartis sought Swissmedic regulatory approval for a drug, which was co-funded by Sida and introduced first in Ghana.Sep 15
• Novartis acquired Regulus Therapeutics in April, while also reportedly weighing a potential deal with Avidity Biosciences.Jun 7
• The European Medicines Agency provided a positive opinion on a drug developed by Novartis.Sep 21
• Novartis' trial results are impacting Royalty Pharma's investment decisions.Sep 5
• Novartis conducted REMODEL trials for remibrutinib.Sep 3